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Abstract
Background: Over the past decade, there has been rising interest in the interaction of 
Pneumocystis with the environment. This interest has arisen in part from the demonstration that 
environmental factors have important effects on the viability and transmission of microbes, 
including Pneumocystis. Environmental factors include climatological factors such as temperature, 
humidity, and precipitation, and air pollution factors including carbon monoxide, nitrogen dioxide, 
sulfur dioxide, and particulate matter.
Methods: We undertook a systematic review in order to identify environmental factors associated 
with Pneumocystis infection or PCP, and their effects on human and animal hosts.
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Results: The systematic review found evidence of associations between Pneumocystis infection 
in animal and human hosts, and climatological and air pollution factors. Data from human studies 
infers that rather than a seasonal association, presentation with PCP appears to be highest when 
the average temperature is between 10 and 20°C. There was evidence of an association with 
hospitalization with PCP and ambient air pollution factors, as well as evidence of an effect of air 
pollution on both systemic and bronchoscopic lavage fluid humoral responses to Pneumocystis. 
Interpretation of human studies was confounded by possible genetically-determined predisposition 
to, or protection from infection.
Conclusions: This systematic review provides evidence of associations between Pneumocystis 
infection in both animal and human hosts, and climatological and environmental air pollution 
factors. This information may lead to an improved understanding of the conditions involved in 
transmission of Pneumocystis in both animal and human hosts. Such knowledge is critical to 
efforts aimed at prevention.
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1. Introduction
Pneumocystis jirovecii is a fungus that continues to be an important cause of pneumonia 
(PCP) in the immunocompromised host and a major cause of death in humans [1]. It is 
estimated that there are more than 400,000 annual cases of PCP worldwide, with over 
52,000 deaths per year [2]. Knowledge of the basic biology of Pneumocystis has long been 
limited by of the lack of a reliable and reproducible method of in vitro cultivation [3] but 
important insights have been gained from both animal and human studies. Pneumocystis 
organisms found in different hosts are morphologically indistinguishable but host species-
specific [1]. Colonization of apparently healthy asymptomatic humans may provide a 
reservoir of P. jirovecii, and transmission of Pneumocystis to both susceptible and healthy 
persons may occur. However, the exact relationship is incompletely understood, and 
environmental reservoirs for the organism have also been suggested. Pneumocystis infection 
is acquired by inhalation, and the infective moiety is the cystic form [4] but the precise 
conditions for airborne transmission are unknown. Traditionally, PCP was thought to be the 
result of reactivation of latent infection acquired early in childhood, but molecular studies 
from PCP outbreaks demonstrate that PCP can also result from recent exposure in an at-risk 
host [5]. As a result, an improved understanding of the conditions involved in transmission is 
critical to efforts at prevention.
Over the past decade, there has been rising interest in the interaction of Pneumocystis with 
the environment. This interest has arisen in part from the demonstration that environmental 
factors have important effects on the viability and transmission of microbes, including 
Pneumocystis. Studies have demonstrated an association between environmental factors and 
the risk of PCP as well as specific antibody responses against P. jirovecii. The environmental 
factors can broadly be divided into two groups: a) climatological factors such as 
temperature, humidity, and precipitation; and b) air pollution factors including carbon 
monoxide (CO), nitrogen dioxide (NO2), sulfur dioxide (SO2) and particulate matter [6]. We 
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undertook this systematic review in order to identify specific environmental factors 
associated with Pneumocystis infection or PCP, and their effects on human and animal hosts. 
Our goal was to comprehensively review the published literature on this topic in order to 
gain insights and advance our understanding of this important human pathogen.
2. Materials and Methods
We sought to identify publications describing associations between environmental factors 
and detection of Pneumocystis in humans and animals, and with development and 
presentation with PCP. We first reviewed English-language published articles of 
Pneumocystis and PCP and associated climatological and air pollution factors for the period 
01 January 1960 to the present day (30 June 2018) using PubMed (US National Library of 
Medicine). The following search terms were used: Pneumocystis [Title] + English 
[Language], then Human [MeSH], then one of the following MeSH: season, climate, air 
pollution, environment, geography, humidity, or temperature. In addition, we reviewed the 
references within each publication for additional articles. Since the first reports of human 
immunodeficiency virus (HIV)-associated PCP in the early 1980s, most cases of PCP in the 
literature have been described in the context of HIV infection.
The scope of the present study was increased to include animals studied in the wild, in 
slaughterhouses, and in research laboratories. The same time period was used and the 
following search terms were used in the literature search: Pneumocystis [Title] + English 
[Language], then, Animal [MeSH], then one of the following MeSH: season, climate, air 
pollution, environment, geography, humidity, or temperature. Inclusion of these animal 
studies was done in order to enhance the findings from human studies and to provide 
important insights that add to our understanding of studies in humans.
Studies identified by the search strategy were divided into three groups:
Group 1: animal studies. Group 2: human studies of HIV-infected and uninfected patients 
with PCP divided based on geographic location. Group 3: human studies of HIV-infected 
patients with PCP associated with ambient air pollutants.
Where specific climatological information (i.e., temperature and humidity/precipitation) was 
not described in a specific publication we used World Weather Online [7]. In addition, as 
this is a systematic review of previously published work, Ethics Committee/IRB approval 
was not required from any of the three centers involved in this work.
3. Results
3.1. Literature Search
The PubMed literature search for the period 01 January 1960 through 30 June 2018 
identified 74 unique full text articles. From these, 53 articles were excluded (after review of 
the full text by LH and RFM), as they were not relevant to the topic, or they were review 
articles that did not contain original data. In addition to the 21 remaining articles, 16 articles 
were identified by hand searching by the authors (LH and RFM). Additionally, the authors 
of some publications identified either by the MeSH search or via the “hand search” were 
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contacted (by RFM) in order to obtain additional information not contained in their original 
published manuscript. Thus, in total 37 articles were identified and were included in the 
systematic review. Figure 1 shows the results of the literature search.
3.2. Animal Studies Showing Associations between Detection of Pneumocystis and 
Seasonal and Environmental Factors
Group 1. Eleven studies in animals (six from Europe, two from South America, two from 
Asia, and one from USA) were identified. Animal hosts were pigs (four studies), wild mouse 
species, shrew species, field voles, rats, hares, crab-eating macaques, and bats (each one 
study), (Table 1) [8–18]. Pneumocystis was detected in all of the animal species studied, 
using a range of techniques including Grocott silver staining, immunohistochemistry, and 
polymerase chain reaction (PCR). Using PCR, Pneumocystis was detected in as few as 4–
5% of pigs in a slaughterhouse [17] to as many as 34.5% of crab-eating macaques living in a 
Primatology Center [12].
The main findings were that in eight of the 11 studies there was a clear seasonal variation in 
detection of Pneumocystis among different hosts, in their natural surroundings [8, 9, 10, 11, 
14, 15, 17, 18]. In the study of macaques housed in a Primatology Center, detection was 
associated with mean precipitation, and in the study of rats in a laboratory facility, 
temperature and humidity had a clear influence on the predominance of different types of 
Pneumocystis. Finally, the study of bats in both captive and wild environments showed no 
association between detection of Pneumocystis and either temperature or humidity, but an 
association with smaller, crowded sedentary colonies at altitudes below 800m above sea 
level.
3.3. Human Studies Showing Associations between Pneumocystis and Seasonal and 
Environmental Factors
Group 2. Twenty-four studies in HIV-infected and uninfected patients with PCP were 
identified and were divided, based on geographic location. Seven studies were from USA, 
two from South America, 11 from Northern Europe, three from Southern Europe, and one 
from Australia, (Table 2) [6, 19–41]. These studies were a mixture of prospective and 
retrospective clinical or laboratory (including autopsy) studies and were national, multi-
center or single center in their design. Two studies were done in infants, the remaining 22 
studies were done in adults. Among the adult studies 19 included only HIV-infected adults, 
two included HIV-infected and uninfected adults, and one included HIV-uninfected adults 
with underlying rheumatologic conditions. In the two studies of infants, subjects were HIV-
uninfected [19–41].
The main findings were that in 18 studies in adults there was evidence of a seasonal and/or 
climatological association and presentation with PCP, or detection at autopsy and two 
studies showed no such association but noted clustering of cases of PCP by Zip Code, and 
another identified that time spent outdoors was associated with risk of PCP. In the remaining 
two studies there was no apparent seasonal or climatologic association with development of 
PCP. However, both studies showed an apparent ethnic predisposition, with patients of black 
African origin being at reduced risk of developing PCP compared to patients who were of 
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Western origin (Table 2). Both studies in infants showed a seasonal variation either in 
detection of P. jirovecii at autopsy, or variation in antibody responses to Pneumocystis major 
surface antigen components.
3.4. Human Studies Showing Associations between Pneumocystis and Ambient Air 
Pollution Factors
Group 3. Four studies (three from USA, one from Spain) reported the impact of ambient air 
pollution factors among HIV-infected adult patients hospitalized with PCP (Table 3) [6, 40, 
42, 43]. Of note two of these four studies are also included in Group 2 [6, 42]. The San 
Francisco studies were single-center, prospective studies while the study from Spain was a 
national study.
The main findings were that one study showed elevated levels of NO2, PM10 and ozone in 
ambient air were associated with increased risk of hospitalization with PCP [40], and in 
another SO2, was associated with increased risk of hospitalization, but the risk was 
attenuated by elevated CO levels [6]. Two further studies that examined serologic responses 
in hospitalized patients with PCP, and showed elevated NO2, and PM10 were independently 
associated with impaired IgM responses to P. jirovecii major surface glycoprotein (Msg) 
constructs in serum [42], and that there was an impaired IgA response to P. jirovecii Msg in 
bronchoscopic lavage (BAL) fluid that was associated with increased ambient ozone 
exposure. Additionally, increased BAL fluid IgA responses were associated with increased 
ambient NO2 exposure [43] (Table 3).
4. Discussion
We believe that the present study is the first systematic review of the relationship between 
Pneumocystis infection in its animal and human hosts, and the effects of climatological and 
air pollution factors in the environment on this relationship. This review found evidence of 
associations between Pneumocystis infection in animal and human hosts, and climatological 
and environmental air pollution factors, but the quality of evidence was poor and was limited 
by inconsistent and incomplete sampling methodology in both animal and human studies.
4.1. Non-Pneumocystis Fungi – Seasonal and Climatological Factors
Climatological factors, including temperature and humidity, are associated with variations in 
concentrations of ascomycetes, basidiomycetes, and other fungi in air [44–48]. A study from 
Porto Alegre, Southern Brazil, showed the highest detection of airborne fungal spores was in 
summer (December-February), when average minimum air temperatures are typically 
between 18 and 21°C [7]. The lowest rates of detection were in the autumn (March-May), 
when average minimum temperatures are typically between 12 and 17°C [45]. A second 
study from Fortaleza, North East Brazil, where the climate is hotter, reported seasonal 
variation in rates of detection of airborne fungi, (higher rates of detection were observed in 
January-April, and lower rates were recorded in July-October [46]. This city experiences a 
rainy season (February-July: rainfall 1883.5 mm, average temperature 26.8°C) and a dry 
season (August-January: rainfall 260 mm, average temperature 27.6°C) [46].
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4.2. Pneumocystis - Seasonal Factors – Average Temperature
In the studies of Pneumocystis in animals studied in the wild, in slaughterhouses, and in 
research laboratories that were identified in this systematic review interpretation of the 
observed seasonal variation is confounded by the fact that none of the studies systematically 
sampled throughout the year, nor sampled in consecutive years, and none of the studies 
included “controls”. Thus, possible alternative explanations for the apparent seasonal 
variation must include closer animal-to-animal proximity within animal colonies, driven by 
climatological factors, and by season, for example by closer co-habitation during the mating 
season for an individual animal host. This potentially increases the chance for airborne or 
“other” animal-to-animal transmission, and thus likelihood of detection by opportunistic, or 
systematic sampling. In the studies of pigs, another factor influencing detection of 
Pneumocystis is the type of husbandry used in rearing the animals, as higher rates of 
detection were observed in semi-intensively farmed animals when compared with pigs who 
were intensively-farmed. This finding has been ascribed to less control of production 
variables in pigs reared semi-intensively [17]. Additionally, detection of Pneumocystis has 
been associated with underlying viral and/or bacterial infection in pigs. It has been 
suggested that these infections may act as potential “immune suppressants” thus permitting 
colonization/infection with Pneumocystis [15, 17]
Taken together the human studies clearly demonstrate evidence of a seasonal and/or 
climatological association and presentation with PCP, or serologic or autopsy detection of 
infection. A seasonal variation in incidence of PCP was first reported in 1991 [19]. 
Subsequently, the relationship between seasonality and temperature and hospitalization with 
PCP has described inconsistent findings with some, but not all studies describing any 
association. In both HIV-infected and uninfected patients the risk of PCP has been observed 
to be higher in summer (London, UK) [28, 35], (Geneva, Switzerland [29] (Munich, 
Germany) [36] and (San Francisco, USA) [6] autumn (Melbourne, Australia) [41], and 
winter (Seville, Spain) [40]. As previously suggested [6], these differing results might be as 
a result of differences in patient populations, climatological factors, geography, 
Pneumocystis genotypes, or to differences in study design [6]. Because of geographical 
climatological differences, it is likely that summer temperatures in one country, or region, 
are similar to autumn or winter temperatures in another geographical location. For example, 
in Spain winters are generally mild (most regions having an average temperature between 10 
and 20°C), and summers are hot (with average temperatures greater than 30°C) [40]. Thus, 
the average temperature in a Spanish winter is similar to that observed in other seasons in 
other countries during which the highest incidence of PCP has been described [40]. In 
London the “peak” summer temperature was 13°C *28], the mean summer temperature in 
San Francisco was 17.6°C [6], and average temperature in Melbourne was between 13.2 and 
20°C [7, 40]. Taken together, interpretation of these data, infer that rather than a seasonal 
association, presentation with PCP appears to be highest during the season of the year when 
the average temperature is between 10 and 20°C [40]. As previously noted [40], among HIV-
infected persons, other confounding factors, including tobacco smoking [24], chronic 
obstructive pulmonary disease, bacterial pneumonia, and colonization of the respiratory tract 
by P. jirovecii, can contribute to increased risk of developing PCP, and also that these 
contributing factors additionally, are potentially affected by climatological factors [24].
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A similar seasonal association is apparent in the two studies of infants done in Chile [25, 
26]. In the autopsy study the highest rate of detection of Pneumocystis was in winter (June-
August), when average maximum temperatures were 16–18°C, and the lowest rate of 
detection was in autumn (March-May), when average maximum temperatures were 20–28°C 
[7, 25]. In the study of serum antibody responses to Pneumocystis MsgA constructs among 
immune competent infants the lowest peaks were also detected in autumn (March-May) 
[26].
4.3. Seasonal Factors – Humidity and Precipitation
There is a less certain association between the climatological variables of humidity and 
precipitation, and detection of Pneumocystis in animal and human hosts, or with 
presentation with PCP in humans. Some animal studies [12, 17, 18] and some human studies 
[20, 27, 28, 33] suggest an association, but others do not. Confounding these observations is 
the fact that data about this climatological variable was not routinely collected in either the 
animal or human studies.
A further potential factor, confounding interpretation of data concerning both temperature 
and humidity/precipitation in humans is that in the EuroSIDA study, which was a 
prospective observational cohort study that reported diagnosis of PCP in North, Central, and 
South Europe, the higher prevalence of PCP described in cooler, wetter North European 
climates might be explained by other logistical factors, including better access to healthcare 
(and so the likelihood of being diagnosed with PCP) in North Europe [30]. A similar 
interpretation can be applied to the findings from another European retrospective multicenter 
study [31].
4.4. Seasonal Factors – Outdoor Activities
The study from Atlanta, USA showed spending time outdoors gardening, camping or hiking 
in the six months prior to hospitalization with pneumonia was strongly associated with risk 
of PCP [21]. Additionally, studies from Cincinnati and San Francisco, USA showed 
clustering of PCP by Zip Codes [22, 24]: the former study showing more cases in affluent 
areas with more green space [22], the latter reporting more cases in residential areas 
containing parks and small yards [24]. Taken together, these three studies infer that 
susceptible individuals are at greater risk of developing PCP if they have increased 
opportunities for being outdoors, and thus possibly for increased environmental exposure to 
Pneumocystis.
4.5. Genetic Factors
Observations from national (Netherlands) and single-site London (UK) cohorts infer that 
there might be an ethnic/genetically-determined predisposition to development of PCP [32, 
37]. Single point mutations (SNPs) in genes associated with innate immune function are 
increasingly recognized as significant factors dictating an individual’s susceptibility to 
infection *49-51]. Two reports describe an association between SNPs and development of 
PCP in HIV-infected individuals [52,53]. The FcγIIa receptor, which binds to immune 
complexes to facilitate uptake of microbes, is encoded by a gene with synonymous 
(functional) polymorphisms that affects binding affinity to IgG. Participants in the 
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Multicenter AIDS Cohort Study (MACS) with the FcγRIIa RR genotype progressed to 
AIDS (i.e., CD4 count <200 cells/uL) faster than participants with RH or HH genotypes 
[52]. By contrast, participants with an FcγRIIa HH genotype progressed more quickly to 
AIDS (defined by development of PCP) than those with other genotypes [52]. While the 
underpinning mechanisms remain uncertain, these results raise intriguing questions about 
the antibodies that opsonize Pneumocystis and interact with FcγRIIa receptors. The 
chemokine receptor CXCR6 is a co-receptor that facilitates fusion of HIV to CD4 cells. The 
ligand for CXCR6 (CCXCL16) is highly expressed in the lungs. A SNP in codon 3 
(CXCR6-E3K) is common in African Americans and rare in Caucasians. The AIDS Link to 
Intravenous Experience (ALIVE) study, a prospective cohort study of predominantly African 
American HIV-infected drug users, examined the relationship of CXCR6 SNPs and 
development of PCP [53]. Time to development of PCP was similar among the genotypes, 
but subjects homozygous or heterozygous for CXCR6–3E were more likely to die after PCP 
(and thus had a shorter survival time) than subjects homozygous for CXCR6–3K [53].
The current epidemiology of pediatric PCP in the USA demonstrates that it is less frequently 
observed in HIV-infected children. By contrast cases associated with hematologic 
malignancy and primary immunodeficiency have become more prominent, infants being the 
most commonly affected [54]. Well-described mutations in MHC class II (bare lymphocyte 
syndrome), recombination activating genes (RAG) −1 and −2, signal transducer and 
activator of transcription (STAT) −3, and IL-21R that can be modeled in genetically 
engineered mice and P. murina infection, provide evidence of genetic susceptibility to 
Pneumocystis infection [55]. Taken together these data suggest a gene-environment 
interaction in the disease.
4.6. Air Pollution
Among the general population it is increasingly evident that ambient air pollution 
contributes to the global burden of respiratory disease, including asthma, Chronic 
Obstructive Pulmonary Disease, and pneumonia [56–65]. The studies identified in this 
systematic review originating from Spain and San Francisco, USA clearly demonstrate an 
association between ambient air pollution factors and presentation of HIV-infected adults 
with PCP [6, 40]. It is intriguing that in one study there was no association with PM10, NO2, 
CO, or ozone, and an association was only evident for SO2 [6]. In the other study NO2, 
PM10, CO, and ozone were associated with risk of hospitalization with PCP [40]. This 
apparent difference may in part be explained by the fact that San Francisco is one of the least 
polluted cities in the United States and so it is possible that levels of these pollutants were 
below thresholds that can trigger respiratory complications [6].
The mechanisms by which ambient air pollution increases susceptibility to pulmonary 
infection are not well defined. Controlled exposure studies of single pollutants that have 
used cells, animals and human subjects indicate that ambient air pollutants alter innate lung 
immunity at multiple levels, including altered muco-ciliary function, respiratory epithelial 
cell dysfunction, impaired alveolar macrophage phagocytosis, and dysfunction of surfactant 
protein A and D [Reviewed in 6]. However, the effects of ambient air pollution factors on 
humoral immunity and serologic responses to pulmonary infection, and the immune-toxic 
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effects of real-life exposures to ambient air pollution factors are poorly understood. In one 
study from San Francisco [42] PM10 and NO2 were independently associated with 
suppressed IgM (but not IgG) responses to Pneumocystis Msg constructs. It was suggested 
that PM10 particles encountering bronchus associated lymphoid tissue, might impair antigen 
presenting cell function, resulting in decreased activation of the humoral immune system and 
suppressed serologic responses [42]. Both animal and human exposure studies have found 
mixed effects of NO2 inhalation on bronchoalveolar and systemic antibody responses [66–
69]. In a second study also from San Francisco patients with PCP increasing exposure to 
ozone was associated with reduced BAL fluid IgA responses to P. jirovecii Msg constructs 
and increasing exposure to NO2 was independently associated with increased BAL fluid IgA 
responses to P. jirovecii Msg [43]. These results might be explained by the observation that 
ozone is a potent oxidant resulting in both bronchoalveolar, and systemic inflammation. 
Animal studies have found that rats in the first two weeks of exposure to ozone demonstrate 
decreased antibody responses to microbial antigens such as Listeria spp [70].
5. Conclusions
This systematic review found evidence of associations between Pneumocystis infection in 
both animal and human hosts, and climatological and environmental air pollution factors. 
These data are limited by inconsistent and incomplete sampling methodology in both animal 
and human studies. Data from human studies infer that rather than a seasonal association, 
presentation with PCP appears to be highest when the average temperature is between 10 
and 20°C. A potential confounder is possible genetically-determined predisposition to, or 
protection from infection. There is evidence of an association with hospitalization with PCP 
and ambient air pollution factors, as well as a clear effect of air pollution on both systemic 
and bronchoscopic lavage fluid humoral responses to Pneumocystis. The results of this 
systematic review provide an improved understanding of the conditions involved in 
transmission of Pneumocystis in both animal and human hosts. Such knowledge is critical to 
efforts aimed at prevention of infection.
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Figure 1. 
Results of literature search.
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ca
v
e) 
tem
pe
rat
ure
 or
 re
lat
ive
 
hu
m
id
ity
.
Es
ga
lh
ad
o,
 e
t a
l [
17
]
20
13
Pi
gs
Sl
au
gh
te
rh
ou
se
s i
n 
th
e 
Li
sb
on
 a
nd
 T
ag
us
 v
al
le
y,
 
Po
rtu
ga
l.
PC
R
Pn
eu
m
oc
ys
tis
 
de
te
ct
ed
 in
 1
4/
21
5 
(7%
) o
f p
igs
. D
ete
cti
on
 ra
tes
 
hi
gh
er
 in
 p
ig
s r
ai
se
d 
in
 C
en
te
r a
nd
 A
lg
ar
v
e 
re
gi
on
s (
10
–1
3%
), 
th
an
 in
 p
ig
s f
ro
m
 L
isb
on
 a
nd
 A
le
nt
ejo
 re
gi
on
s (
4–
5%
). N
o 
as
so
ci
at
io
n 
w
ith
 m
ed
ia
n 
te
m
pe
ra
tu
re
; a
ss
oc
ia
tio
n 
w
ith
 ex
tr
em
el
y 
lo
w
 a
n
d 
hi
gh
 p
re
ci
pi
ta
tio
n 
ra
te
s. 
D
et
ec
tio
n 
m
or
e 
lik
el
y 
in
 se
m
i-
in
te
ns
iv
el
y 
fa
rm
ed
 p
ig
s (
10
%)
, th
an
 in
 in
ten
siv
el
y 
fa
rm
ed
 p
ig
s 
(5%
)
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St
ud
y 
au
th
or
s
Ye
a
r
Sp
ec
ie
s
Lo
ca
tio
n
M
et
ho
ds
M
ai
n 
fin
di
ng
s
W
ei
ss
en
ba
ch
e 
r-L
an
g,
 
et
 a
l [
18
]
20
16
Pi
gs
In
st
itu
te
 o
f P
at
ho
lo
gy
 a
nd
 
Fo
re
n
sic
 V
et
er
in
ar
y 
M
ed
ic
in
e,
 V
ie
nn
a,
 A
us
tri
a.
IS
H
/P
CR
11
0 
Pn
eu
m
oc
ys
tis
 
po
sit
iv
e 
pi
gs
 w
ith
 p
ne
um
on
ia
; m
an
y 
al
so
 h
ad
 
v
ira
l (
PC
V2
, P
RR
SV
,
 
TT
Su
V
1,
 T
TS
uV
2),
 an
d/o
r b
ac
ter
ial
 (B
. 
br
on
ch
ise
pt
ica
,
 
P. 
m
u
lto
ci
da
,
 
M
. h
yo
pn
eu
m
on
ia
e) 
inf
ec
tio
n. 
79
% 
o
f m
od
er
at
e 
an
d 
se
v
er
e 
Pn
eu
m
oc
ys
tis
 
se
en
 in
 W
in
te
r-S
pr
in
g 
(D
ec
em
be
r-M
ay
).
K
ey
: P
CR
 =
 p
ol
ym
er
as
e 
ch
ai
n 
re
ac
tio
n;
 IS
H
 =
 in
 si
tu
 h
yb
rid
iz
at
io
n;
 P
CV
2 
= 
po
rc
in
e 
ci
rc
ov
iru
s t
yp
e 
2;
 P
RR
SV
 =
 p
or
ci
ne
 re
pr
od
uc
tiv
e 
an
d 
re
sp
ira
to
ry
 sy
nd
ro
m
e 
vi
ru
s; 
TT
Su
V
1,
 T
TS
uV
2 
= 
to
rq
ue
 te
no
 su
s 
v
iru
s t
yp
e 
1 
an
d 
2.
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Ta
bl
e 
2
H
um
an
 st
ud
ie
s s
ho
w
in
g 
as
so
ci
at
io
ns
 b
et
w
ee
n 
Pn
eu
m
oc
ys
tis
 
an
d 
se
as
on
al
 a
nd
 e
nv
iro
nm
en
ta
l f
ac
to
rs
.
R
eg
io
n/
 S
tu
dy
 a
ut
ho
rs
Ye
a
r
Lo
ca
tio
n
M
et
ho
ds
M
ai
n 
fin
di
ng
s
U
SA
H
oo
v
er
,
 
et
 a
l [
19
]
19
91
M
A
CS
 c
oh
or
t: 
Fo
u
r 
U
S 
ci
tie
s
Fo
u
r 
ce
n
tr
e 
re
tr
os
pe
ct
iv
e 
co
ho
rt 
stu
dy
.
In
ci
de
nc
e 
of
 P
CP
 g
re
at
er
 in
 c
ol
de
r c
iti
es
 (C
hic
ag
o &
 Pi
tts
bu
rg
h) 
tha
n i
n 
w
ar
m
er
 c
iti
es
 (B
alt
im
ore
 &
 L
os
 A
ng
ele
s):
 PC
P d
iag
no
ses
 pe
ak
ed
 in
 M
ay
 - 
Ju
ne
 a
nd
 w
er
e 
lo
w
es
t i
n 
N
ov
em
be
r -
 D
ec
em
be
r.
B
ac
ch
et
ti 
[2
0]
19
94
U
SA
A
na
ly
sis
 o
f m
on
th
ly
 tr
en
ds
 in
 A
ID
S 
di
ag
no
se
s a
m
on
g 
ad
ol
es
ce
nt
s a
nd
 a
du
lts
 
re
po
rte
d 
to
 C
D
C.
Se
as
on
al
 p
at
te
rn
 o
f P
CP
,
 
w
ith
 a
 p
ea
k 
in
 M
ar
ch
. M
or
e 
PC
P 
in
 M
SM
/b
ise
x
u
al
 
m
en
 in
 su
m
m
er
 in
 W
es
t o
f U
SA
 (i
nc
lud
es 
Sa
n F
ran
cis
co
 an
d L
os
 A
ng
ele
s) 
w
hi
ch
 is
 d
rie
r t
ha
n 
re
st 
of
 U
SA
 a
t t
hi
s t
im
e.
N
av
in
, e
t a
l [
21
]
20
00
A
tla
nt
a,
 G
eo
rg
ia
Tw
o
 c
en
tr
e 
sin
gl
e 
ci
ty
 re
tro
sp
ec
tiv
e 
co
ho
rt 
stu
dy
.
PC
P 
as
so
ci
at
ed
 w
ith
 o
ut
do
or
 a
ct
iv
iti
es
 (g
ar
de
ni
ng
, h
ik
in
g 
or
 c
am
pi
ng
).
D
oh
n,
 e
t a
l[2
2]
20
00
Ci
nc
in
na
ti,
 O
hi
o
Si
ng
le
 c
en
tre
 c
oh
or
t s
tu
dy
.
Cl
us
te
rin
g 
of
 P
CP
 c
as
es
 b
y 
Zi
p 
co
de
. M
os
t c
as
es
 o
cc
ur
re
d 
in
 a
ffl
ue
nt
 a
re
as
 
w
ith
 m
or
e 
gr
ee
n 
sp
ac
e.
 N
o 
se
as
on
al
 v
ar
ia
tio
n.
M
or
ris
, e
t a
l [
23
]
20
00
Sa
n 
Fr
an
ci
sc
o,
 C
al
ifo
rn
ia
Si
ng
le
 c
en
tre
 c
oh
or
t s
tu
dy
.
Cl
us
te
rin
g 
of
 P
CP
 c
as
es
 b
y 
Zi
p 
co
de
. M
os
t c
as
es
 o
cc
ur
re
d 
in
 m
or
e 
re
sid
en
tia
l a
re
as
 th
at
 c
on
ta
in
 p
ar
ks
 a
nd
 sm
al
l y
ar
ds
. N
o 
se
as
on
al
 v
ar
ia
tio
n.
M
or
ris
, e
t a
l [
24
]
20
04
M
A
CS
 c
oh
or
t F
o
u
r 
U
S 
ci
tie
s
R
et
ro
sp
ec
tiv
e 
co
ho
rt 
stu
dy
 o
f p
at
ie
nt
s 
w
ho
 h
ad
 n
ec
ro
ps
y. 
PC
R 
de
te
ct
io
n 
of
 P
.
 
jiro
ve
ci
i.
R
at
es
 o
f c
ol
on
iz
at
io
n 
(de
ter
mi
ne
d b
y P
CR
) g
rea
ter
 in
 ci
ga
re
tte
 s
m
ok
er
s.
 
D
et
ec
tio
n 
ra
te
s h
ig
he
r i
n 
Ch
ic
ag
o 
an
d 
Pi
tts
bu
rg
h 
(70
.4%
 an
d 6
1.5
%)
 th
an
 in
 
B
al
tim
or
e 
an
d 
Lo
s A
ng
el
es
 (4
2.3
% 
an
d 1
6%
).
D
jaw
e,
 e
t a
l [
6]
20
13
Sa
n 
Fr
an
ci
sc
o,
 C
al
ifo
rn
ia
Si
ng
le
 c
en
tre
 c
oh
or
t s
tu
dy
.
Se
as
on
al
 v
ar
ia
tio
n 
in
 h
os
pi
ta
liz
at
io
n 
w
ith
 P
CP
; p
ea
k 
in
 su
m
m
er
 (J
un
e-
A
ug
us
t).
So
ut
h 
Am
er
ica
Va
rg
as
, 
et
 a
l [
25
]
20
05
Sa
nt
ia
go
, C
hi
le
A
ut
op
sy
 st
ud
y, 
tw
o
 c
hi
ld
re
n’
s h
os
pi
ta
ls.
 
PC
R 
de
te
ct
io
n 
of
 P.
 
jiro
ve
ci
i.
P. 
jiro
ve
ci
i D
N
A
 d
et
ec
te
d 
in
 5
1.
7%
 o
f i
m
m
un
e c
om
pe
te
nt
 in
fa
n
ts
 d
yi
ng
 in
 
th
e 
co
m
m
un
ity
 a
nd
 in
 2
0%
 d
yi
ng
 in
 h
os
pi
ta
l. 
Se
as
on
al
 v
ar
ia
tio
n 
in
 d
et
ec
tio
n:
 
53
%
 in
 W
in
te
r (
Ju
ne
 - A
ug
us
t) 
wh
en
 m
ax
im
um
 te
mp
era
tur
e =
 16
–1
8°
C.
 an
d 
30
%
 in
 A
ut
um
n 
(M
arc
h -
 M
ay
) w
he
n m
ax
im
um
 te
mp
era
tur
e =
20
–2
8°
C.
D
jaw
e,
 e
t a
l [
26
]
20
10
Sa
nt
ia
go
, C
hi
le
Pr
os
pe
ct
iv
e 
co
ho
rt 
stu
dy
.
Se
as
on
al
 v
ar
ia
tio
n 
in
 se
ru
m
 a
nt
ib
od
y 
tit
er
s t
o 
P. 
jiro
ve
ci
i a
m
o
n
g 
im
m
un
e 
co
m
pe
te
nt
 in
fa
n
ts
. M
sg
A
 a
nt
ib
od
y 
tit
er
s h
ig
he
st 
in
 S
pr
in
g 
(S
ep
tem
be
r -
 
N
ov
em
be
r) 
an
d l
ow
es
t i
n 
A
ut
um
n 
(M
arc
h- 
M
ay
) M
sg
C 
tite
rs 
hig
he
st 
in 
Su
m
m
er
 (D
ec
em
be
r -
 Fe
bru
ary
) a
nd
 W
in
te
r (
Ju
ne
 - A
ug
us
t)
N
or
th
er
n 
Eu
ro
pe
Se
tn
es
 &
 G
en
ne
r [
27
]
19
86
Co
pe
nh
ag
en
, D
en
m
ar
k
Tw
o
 h
os
pi
ta
l a
ut
op
sy
 st
ud
y.
Pn
eu
m
oc
ys
tis
 
id
en
tif
ie
d 
in
 8
3/
17
62
 (4
.7%
) o
f a
uto
ps
ies
 at
 R
igh
os
pit
ale
t a
nd
 
Fi
ns
en
in
sti
tu
tte
t H
os
pi
ta
ls 
19
79
–1
98
4.
 L
ow
er
 d
et
ec
tio
n 
of
 P
ne
um
oc
ys
tis
 
o
bs
er
ve
d 
in
 1
98
1 
co
rre
sp
on
de
d 
w
ith
 lo
w
 te
m
pe
ra
tu
re
, l
ow
 v
ap
or
 p
re
ss
ur
e,
 
an
d 
lo
w
 h
um
id
ity
.
 
H
ig
he
r r
at
e 
of
 d
et
ec
tio
n 
in
 1
98
2–
3 
co
rre
sp
on
de
d 
w
ith
 
hi
gh
er
 av
er
ag
e 
te
m
pe
ra
tu
re
 a
nd
 v
ap
or
 p
re
ss
ur
e.
M
ill
er
,
 
G
ra
nt
 &
 F
o
le
y 
[2
8]
19
92
Lo
nd
on
, U
K
Si
ng
le
 c
en
tre
 re
tro
sp
ec
tiv
e 
co
ho
rt 
stu
dy
.
Se
as
on
al
 v
ar
ia
tio
n 
in
 P
CP
: h
ig
he
st 
in
 Ju
ne
-J
ul
y 
an
d 
Se
pt
em
be
r, 
fo
llo
w
in
g 
pe
rio
ds
 w
ith
 lo
w
 r
ai
nf
al
l a
nd
 te
m
pe
ra
tu
re
s <
13
°
C.
Va
n
he
m
s, 
H
irs
ch
el
 &
 M
or
ab
ia
 
[2
9]
19
92
G
en
ev
a,
 S
w
itz
er
la
nd
Si
ng
le
 c
en
tre
 re
tro
sp
ec
tiv
e 
co
ho
rt 
stu
dy
.
Se
as
on
al
 v
ar
ia
tio
n 
in
 P
CP
 c
as
es
: h
ig
he
st 
in
 Ju
ne
 - 
Se
pt
em
be
r. 
Se
as
on
al
 
v
ar
ia
tio
n 
no
 lo
ng
er
 o
bs
er
ve
d 
af
te
r i
nt
ro
du
ct
io
n 
of
 P
CP
 p
ro
ph
yl
ax
is.
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R
eg
io
n/
 S
tu
dy
 a
ut
ho
rs
Ye
a
r
Lo
ca
tio
n
M
et
ho
ds
M
ai
n 
fin
di
ng
s
Lu
nd
gr
en
, e
t a
l [
30
]
19
95
Co
pe
nh
ag
en
, D
en
m
ar
k
M
ul
tic
en
te
r p
ro
sp
ec
tiv
e 
st
ud
y 
in
 
N
or
th
er
n,
 C
en
tra
l a
nd
 S
ou
th
er
n 
Eu
ro
pe
.
In
ci
de
nc
e 
of
 P
CP
 h
ig
he
r i
n 
co
ol
er
 c
lim
at
es
 (N
ort
he
rn 
Eu
rop
e),
 co
mp
are
d 
w
ith
 C
en
tra
l o
r S
ou
th
er
n 
Eu
ro
pe
.
D
el
m
as
, e
t a
l [
31
]
19
95
Pa
ris
, F
ra
nc
e
M
ul
tic
en
te
r r
et
ro
sp
ec
tiv
e 
st
ud
y 
in
 e
ig
ht
 
Eu
ro
pe
an
 c
ou
nt
rie
s a
nd
 in
 A
m
ste
rd
am
, 
N
et
he
rla
nd
s.
In
ci
de
nc
e 
of
 A
ID
S-
de
fin
in
g 
PC
P 
hi
gh
er
 in
 G
er
m
an
y,
 
Sw
itz
er
la
nd
, a
nd
 U
K
 
(N
ort
he
rn/
Ce
ntr
al 
Eu
rop
e),
 an
d l
ow
es
t i
n 
Po
rtu
ga
l a
nd
 It
al
y 
(S
ou
the
rn 
Eu
ro
pe
).
D
el
 A
m
o,
 e
t a
l [
32
]
19
98
Lo
nd
on
, U
K
El
ev
en
 c
en
te
r r
et
ro
sp
ec
tiv
e 
co
ho
rt 
stu
dy
.
PC
P 
w
as
 p
re
se
nt
in
g 
A
ID
S-
de
fin
in
g 
co
nd
iti
on
 in
 5
2/
31
3 
(17
%)
 of
 bl
ac
k 
A
fri
ca
ns
, c
om
pa
re
d 
w
ith
 5
2/
31
4 
(34
%)
 of
 no
n-A
fri
ca
ns
 liv
in
g 
in
 L
on
do
n.
Lu
bi
s, 
et
 a
l [
33
]
20
03
Lo
nd
on
, U
K
Si
ng
le
 c
en
tre
 re
tro
sp
ec
tiv
e 
co
ho
rt 
stu
dy
.
Va
ria
tio
n 
in
 m
on
th
ly
 in
ci
de
nc
e 
of
 P
CP
: h
ig
he
st 
in
 Ja
nu
ar
y 
(16
.9%
) 
as
so
ci
at
ed
 w
ith
 lo
w
 m
o
n
th
ly
 ra
in
fa
ll 
(<
35
 m
m/
mo
nth
). J
an
ua
ry 
pe
ak
 m
ore
 
pr
om
in
en
t i
n 
so
m
e 
ye
ar
s a
nd
 n
ot
 ev
id
en
t i
n 
ot
he
r y
ea
rs
. O
th
er
 p
ea
ks
 in
 A
pr
il 
(9.
8%
) a
nd
 Se
pte
mb
er 
(9.
6%
) n
ot 
ass
oc
iat
ed
 w
ith
 ra
inf
al
l.
M
ill
er
,
 
et
 a
l [
34
]
20
07
Lo
nd
on
, U
K
Si
ng
le
 c
en
tre
 re
tro
sp
ec
tiv
e 
co
ho
rt 
stu
dy
.
 
G
en
ot
yp
in
g 
of
 P.
 
jiro
ve
ci
i i
so
la
te
s a
t m
t 
LS
U
 rR
NA
 lo
cu
s.
A
ss
oc
ia
tio
n 
be
tw
ee
n 
G
en
ot
yp
e 
2 
an
d 
m
ix
ed
 g
en
ot
yp
es
, a
nd
 se
as
on
/m
on
th
: 
pe
ak
s i
n 
Ju
ne
 - 
Ju
ly
,
 
an
d 
M
ay
 - 
Ju
ne
 a
nd
 S
ep
te
m
be
r, 
re
sp
ec
tiv
el
y.
 
N
o 
as
so
ci
at
io
n 
be
tw
ee
n 
te
m
pe
ra
tu
re
, o
r r
ai
nf
al
l a
nd
 sp
ec
ifi
c 
ge
no
ty
pe
s.
W
al
ze
r, 
et
 a
l [
35
]
20
08
Lo
nd
on
, U
K
Si
ng
le
 c
en
tre
 re
tro
sp
ec
tiv
e 
co
ho
rt 
stu
dy
.
Se
as
on
al
 v
ar
ia
tio
n 
in
 p
re
se
nt
at
io
n 
of
 P
CP
 o
v
er
 a
 2
1 
ye
ar
 p
er
io
d:
 h
ig
he
st 
in
 
su
m
m
er
 (J
un
e -
 A
ug
us
t; 2
9.8
%)
 an
d l
ow
es
t i
n 
w
in
te
r (
De
ce
mb
er 
- F
eb
rua
ry;
 
21
.9
%
).
Si
ng
, e
t a
l [
36
]
20
09
M
un
ic
h,
 G
er
m
an
y
Si
ng
le
 c
en
tre
 c
oh
or
t s
tu
dy
.
Se
as
on
al
 v
ar
ia
tio
n 
in
 c
as
es
 o
f P
CP
: p
ea
k 
in
 su
m
m
er
 (M
ay
 - A
ug
us
t).
 M
ea
n 
te
m
pe
ra
tu
re
 (b
u
t n
ot
 ra
in
fa
ll 
or
 w
in
d 
str
en
gt
h) 
ass
oc
iat
ed
 w
ith
 in
cid
en
ce
 of
 
PC
P.
Sc
ho
ffe
le
n,
 e
t a
l [
37
]
20
13
N
et
he
rla
nd
s
AT
H
EN
A
 n
at
io
na
l o
bs
er
va
tio
na
l c
oh
or
t 
st
ud
y.
PC
P 
oc
cu
rre
d 
le
ss
 fr
eq
ue
nt
ly
 in
 p
at
ie
nt
s o
rig
in
at
in
g 
fro
m
 su
b-
 S
ah
ar
an
 
A
fri
ca
 c
om
pa
re
d 
to
 p
at
ie
nt
s o
f W
es
te
rn
 o
rig
in
 (W
es
te
rn
 E
ur
op
e,
 N
ew
 
Ze
al
an
d,
 A
us
tra
lia
); 
ad
jus
ted
 O
dd
s R
ati
o =
 0.
21
 (0
.15
–0
.29
).
So
ut
he
rn
 E
ur
op
e
Va
re
la
, e
t a
l [
38
]
20
04
Se
v
ill
e,
 S
pa
in
Si
ng
le
 c
en
tre
 c
oh
or
t s
tu
dy
.
 
H
IV
-
po
sit
iv
e 
an
d 
H
IV
-
u
n
in
fe
ct
ed
 p
at
ie
nt
s w
ith
 P
CP
.
In
v
er
se
 c
o
rr
el
at
io
n 
be
tw
ee
n 
in
ci
de
nc
e 
of
 P
CP
 a
nd
 m
ea
n 
am
bi
en
t 
te
m
pe
ra
tu
re
. H
ig
he
st 
nu
m
be
r o
f c
as
es
 in
 w
in
te
r (
Jan
ua
ry-
M
arc
h, 
wi
th 
pe
ak
 
in
 F
eb
ru
ar
y) 
wh
en
 m
ea
n m
ini
mu
m 
tem
pe
rat
ure
 w
as
 7
–9
.7
°
C 
(an
d a
v
er
ag
e 
te
m
pe
ra
tu
re
 w
as
 1
0–
16
.5
 °C
*).
 N
o a
sso
cia
tio
n w
ith
 hu
mi
dit
y.
Ca
ld
er
on
, e
t a
l [
39
]
20
04
A
na
da
lu
sia
, S
pa
in
Th
irt
y 
tw
o
 p
ub
lic
 h
os
pi
ta
ls 
in
 so
ut
he
rn
 
Sp
ai
n.
 H
IV
-
po
sit
iv
e 
an
d 
H
IV
-
u
n
in
fe
ct
ed
 
pa
tie
nt
s w
ith
 P
CP
.
Se
as
on
al
 v
ar
ia
tio
n 
in
 P
CP
: h
ig
he
st 
in
 w
in
te
r (
De
ce
mb
er 
- F
eb
rua
ry:
 30
.5%
 of
 
al
l c
as
es
), c
om
pa
red
 w
ith
 sp
rin
g (
23
.9%
), s
um
me
r (
23
.7%
), a
nd
 au
tum
n 
(21
.9%
). A
dd
itio
na
l p
ea
k i
n M
ay
.
A
lv
ar
o
-M
ec
a,
 e
t a
l [
39
]
20
15
Sp
ai
n
R
et
ro
sp
ec
tiv
e 
n
at
io
na
l s
tu
dy
 o
f 
ho
sp
ita
liz
ed
 H
IV
-
po
sit
iv
e 
pa
tie
nt
s w
ith
 
PC
P.
M
os
t c
as
es
 o
f P
CP
 o
cc
ur
re
d 
in
 w
in
te
r (
De
ce
mb
er 
- F
eb
rua
ry)
, fe
w
es
t i
n 
su
m
m
er
 (J
un
e -
 A
ug
us
t),
 co
rre
sp
on
din
g t
o l
ow
es
t (
10
– 2
0 °
C)
 an
d h
igh
est
 
te
m
pe
ra
tu
re
s, 
re
sp
ec
tiv
el
y.
A
us
tra
lia
Ta
dr
os
, e
t a
l [
40
]
20
17
M
el
bo
ur
ne
, A
us
tra
lia
R
et
ro
sp
ec
tiv
e 
sin
gl
e 
ce
nt
er
 st
ud
y 
of
 
pa
tie
nt
s w
ith
 sy
ste
m
ic
 a
ut
oi
m
m
un
e 
rh
eu
m
at
ic
 d
ise
as
e.
PC
P 
m
os
t c
om
m
on
ly
 p
re
se
nt
ed
 in
 A
ut
um
n 
(M
arc
h -
 M
ay
) w
he
n a
v
er
ag
e 
te
m
pe
ra
tu
re
 w
as
 1
3.
2–
20
°C
; n
o 
ca
se
s o
cc
ur
re
d 
in
 W
in
te
r (
Ju
ne
 - A
ug
us
t) 
w
he
n 
av
er
ag
e 
te
m
pe
ra
tu
re
 w
as
 1
0–
 1
2°
C*
.
K
ey
: M
A
CS
 =
 M
ul
ti-
ce
nt
er
 A
ID
S 
co
ho
rt 
stu
dy
; M
SM
 =
 m
en
 w
ho
 h
av
e 
se
x
 w
ith
 m
en
; P
CP
 =
 P
ne
um
oc
ys
tis
 jir
ov
ec
ii 
pn
eu
m
on
ia
; C
D
C 
= 
Ce
nt
er
s f
or
 D
ise
as
e 
Co
nt
ro
l a
nd
 P
re
v
en
tio
n;
 A
TH
EN
A
 =
 A
ID
S 
Th
er
ap
y 
Ev
al
ua
tio
n 
in
 th
e 
N
et
he
rla
nd
s; 
M
sg
 =
 m
ajo
r s
urf
ac
e 
gl
yc
op
ro
te
in
; P
CR
 =
 p
ol
ym
er
as
e 
ch
ai
n 
re
ac
tio
n;
 m
t L
SU
 rR
NA
 =
 m
ito
ch
on
dr
ia
l l
ar
ge
 su
bu
n
it 
rib
os
om
al
 R
NA
.
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*
da
ta
 fr
om
 W
o
rld
 W
ea
th
er
 O
nl
in
e 
[7
].
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Ta
bl
e 
3
H
um
an
 st
ud
ie
s s
ho
w
in
g 
as
so
ci
at
io
ns
 b
et
w
ee
n 
Pn
eu
m
oc
ys
tis
 
an
d 
am
bi
en
t a
ir 
po
llu
tio
n 
fa
ct
or
s.
St
ud
y 
au
th
or
s
Ye
a
r
Lo
ca
tio
n
M
et
ho
ds
M
ai
n 
fin
di
ng
s
D
jaw
e,
 e
t a
l [
6]
20
13
Sa
n 
Fr
an
ci
sc
o,
 U
SA
Si
ng
le
 c
en
te
r p
ro
sp
ec
tiv
e 
co
ho
rt 
stu
dy
 o
f h
os
pi
ta
lis
ed
 
H
IV
-
in
fe
ct
ed
 p
at
ie
nt
s w
ith
 P
CP
.
 
Cl
im
at
ol
og
ic
 a
nd
 a
ir 
po
llu
tio
n 
da
ta
.
In
cr
ea
se
s i
n 
SO
2 
le
v
el
s a
ss
oc
ia
te
d 
w
ith
 p
re
se
nt
at
io
n 
w
ith
 P
CP
.
 
Ef
fe
ct
 o
f S
O
2 
at
te
nu
at
ed
 b
y 
ris
es
 in
 C
O
 le
v
el
s.
B
lo
un
t, 
et
 a
l [
42
]
20
13
Sa
n 
Fr
an
ci
sc
o,
 U
SA
Si
ng
le
 c
en
te
r p
ro
sp
ec
tiv
e 
co
ho
rt 
stu
dy
 o
f h
os
pi
ta
lis
ed
 
H
IV
-
in
fe
ct
ed
 p
at
ie
nt
s w
ith
 P
CP
.
 
Cl
im
at
ol
og
ic
 a
nd
 a
ir 
po
llu
tio
n 
da
ta
.
In
cr
ea
sin
g 
ex
po
su
re
 to
 P
M
10
 
an
d 
N
O
2 
in
de
pe
nd
en
tly
 a
ss
oc
ia
te
d 
w
ith
 re
du
ce
d 
se
ru
m
 Ig
M
 re
sp
on
se
s t
o 
P. 
jiro
ve
ci
i M
sg
.
A
lv
ar
o
-M
ec
a,
 e
t a
l [
40
]
20
15
Sp
ai
n
N
at
io
na
l s
tu
dy
 o
f h
os
pi
ta
liz
ed
 H
IV
-
po
sit
iv
e 
pa
tie
nt
s 
w
ith
 P
CP
.
 
Cl
im
at
ol
og
ic
 a
nd
 a
ir 
po
llu
tio
n 
da
ta
.
H
ig
he
r c
on
ce
nt
ra
tio
ns
 o
f N
O
2,
 
PM
10
,
 
CO
, a
nd
 o
zo
ne
 a
ss
oc
ia
te
d 
w
ith
 in
cr
ea
se
d 
lik
el
ih
oo
d 
of
 h
os
pi
ta
liz
at
io
n 
w
ith
 P
CP
.
B
lo
un
t, 
et
 a
l [
43
]
20
17
Sa
n 
Fr
an
ci
sc
o,
 U
SA
Si
ng
le
 c
en
te
r p
ro
sp
ec
tiv
e 
co
ho
rt 
stu
dy
.
 
Cl
im
at
ol
og
ic
 a
nd
 
ai
r p
ol
lu
tio
n 
da
ta
.
In
cr
ea
sin
g 
ex
po
su
re
 to
 o
zo
ne
 a
ss
oc
ia
te
d 
w
ith
 re
du
ce
d 
BA
L 
flu
id
 Ig
A
 re
sp
on
se
s 
to
 P.
 
jiro
ve
ci
i M
sg
, a
nd
 N
O
2 
in
de
pe
nd
en
tly
 a
ss
oc
ia
te
d 
w
ith
 in
cr
ea
se
d 
BA
L 
flu
id
 
Ig
A
 re
sp
on
se
s t
o 
P. 
jiro
ve
ci
i M
sg
.
K
ey
: H
IV
 =
 h
um
an
 im
m
un
od
ef
ic
ie
nc
y 
vi
ru
s; 
PC
P 
= 
Pn
eu
m
oc
ys
tis
 
pn
eu
m
on
ia
; S
O
2 
=
 s
u
fu
r d
io
xi
de
; C
O
 =
 c
ar
bo
n 
m
on
ox
id
e;
 N
O
2 
=
 n
itr
og
en
 d
io
xi
de
; P
M
10
 
=
 p
ar
tic
ul
at
e 
m
at
te
r <
10
 μ
m
 in
 d
ia
m
et
er
; M
sg
 
=
 m
ajo
r s
urf
ac
e 
gl
yc
op
ro
te
in
; B
A
L 
= 
Br
on
ch
oa
lv
eo
la
r l
av
ag
e.
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